{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T15:37:58Z","timestamp":1757777878369,"version":"3.37.3"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"5-6","license":[{"start":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T00:00:00Z","timestamp":1650931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T00:00:00Z","timestamp":1650931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"FCT","award":["UIDP\/04378\/2020","UIDB\/04378\/2020"],"award-info":[{"award-number":["UIDP\/04378\/2020","UIDB\/04378\/2020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflamm. Res."],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s00011-022-01574-2","type":"journal-article","created":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T15:09:31Z","timestamp":1650985771000},"page":"591-602","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Inflammatory biomarkers in staging of chronic kidney disease: elevated TNFR2 levels accompanies renal function decline"],"prefix":"10.1007","volume":"71","author":[{"given":"Irina","family":"Lousa","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3941-6850","authenticated-orcid":false,"given":"Lu\u00eds","family":"Belo","sequence":"additional","affiliation":[]},{"given":"Maria Jo\u00e3o","family":"Valente","sequence":"additional","affiliation":[]},{"given":"Susana","family":"Rocha","sequence":"additional","affiliation":[]},{"given":"In\u00eas","family":"Pregui\u00e7a","sequence":"additional","affiliation":[]},{"given":"Petronila","family":"Rocha-Pereira","sequence":"additional","affiliation":[]},{"given":"Idalina","family":"Beir\u00e3o","sequence":"additional","affiliation":[]},{"given":"Filipe","family":"Mira","sequence":"additional","affiliation":[]},{"given":"Rui","family":"Alves","sequence":"additional","affiliation":[]},{"given":"Fl\u00e1vio","family":"Reis","sequence":"additional","affiliation":[]},{"given":"Alice","family":"Santos-Silva","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2022,4,26]]},"reference":[{"key":"1574_CR1","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/978-981-13-8871-2_18","volume":"1165","author":"XM Meng","year":"2019","unstructured":"Meng XM. Inflammatory mediators and renal fibrosis. Adv Exp Med Biol. 2019;1165:381\u2013406. https:\/\/doi.org\/10.1007\/978-981-13-8871-2_18.","journal-title":"Adv Exp Med Biol"},{"key":"1574_CR2","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/MNH.0b013e32834ad504","volume":"20","author":"T Miyamoto","year":"2011","unstructured":"Miyamoto T, Carrero JJ, Stenvinkel P. Inflammation as a risk factor and target for therapy in chronic kidney disease. Curr Opin Nephrol Hypertens. 2011;20:662\u20138. https:\/\/doi.org\/10.1097\/MNH.0b013e32834ad504.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"1574_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.15420\/ecr.2018.33.1","volume":"14","author":"S Tsalamandris","year":"2019","unstructured":"Tsalamandris S, Antonopoulos AS, Oikonomou E, Papamikroulis G-A, Vogiatzi G, Papaioannou S, Deftereos S, Tousoulis D. The role of inflammation in diabetes: current concepts and future perspectives. Eur Cardiol. 2019;14:50\u20139. https:\/\/doi.org\/10.15420\/ecr.2018.33.1.","journal-title":"Eur Cardiol"},{"key":"1574_CR4","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1053\/j.ajkd.2018.12.044","volume":"74","author":"E Ku","year":"2019","unstructured":"Ku E, Lee BJ, Wei J, Weir MR. Hypertension in CKD: core curriculum 2019. Am J Kidney Dis. 2019;74:120\u201331. https:\/\/doi.org\/10.1053\/j.ajkd.2018.12.044.","journal-title":"Am J Kidney Dis"},{"key":"1574_CR5","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.15420\/ecr.2020.50","volume":"16","author":"N Arnold","year":"2021","unstructured":"Arnold N, Lechner K, Waldeyer C, Shapiro MD, Koenig W. Inflammation and cardiovascular disease: the future. Eur Cardiol. 2021;16:e20\u2013e20. https:\/\/doi.org\/10.15420\/ecr.2020.50.","journal-title":"Eur Cardiol"},{"key":"1574_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.01192","author":"V Andrade-Oliveira","year":"2019","unstructured":"Andrade-Oliveira V, Foresto-Neto O, Watanabe IKM, Zatz R, C\u00e2mara NOS. Inflammation in renal diseases: new and old players. Front Pharmacol. 2019. https:\/\/doi.org\/10.3389\/fphar.2019.01192.","journal-title":"Front Pharmacol"},{"key":"1574_CR7","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1159\/000368940","volume":"39","author":"OM Akchurin","year":"2015","unstructured":"Akchurin OM, Kaskel F. Update on inflammation in chronic kidney disease. Blood Purif. 2015;39:84\u201392. https:\/\/doi.org\/10.1159\/000368940.","journal-title":"Blood Purif"},{"key":"1574_CR8","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.2215\/CJN.03500412","volume":"7","author":"J Gupta","year":"2012","unstructured":"Gupta J, Mitra N, Kanetsky PA, Devaney J, Wing MR, Reilly M, Shah VO, Balakrishnan VS, Guzman NJ, Girndt M, et al. Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC. Clin J Am Soc Nephrol: CJASN. 2012;7:1938\u201346. https:\/\/doi.org\/10.2215\/CJN.03500412.","journal-title":"Clin J Am Soc Nephrol: CJASN"},{"key":"1574_CR9","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/ki.2008.351","volume":"74","author":"DO Schlondorff","year":"2008","unstructured":"Schlondorff DO. Overview of factors contributing to the pathophysiology of progressive renal disease. Kidney Int. 2008;74:860\u20136. https:\/\/doi.org\/10.1038\/ki.2008.351.","journal-title":"Kidney Int"},{"key":"1574_CR10","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nrneph.2012.41","volume":"8","author":"GH Heine","year":"2012","unstructured":"Heine GH, Ortiz A, Massy ZA, Lindholm B, Wiecek A, Mart\u00ednez-Castelao A, Covic A, Goldsmith D, S\u00fcleymanlar G, London GM, et al. Monocyte subpopulations and cardiovascular risk in chronic kidney disease. Nat Rev Nephrol. 2012;8:362\u20139. https:\/\/doi.org\/10.1038\/nrneph.2012.41.","journal-title":"Nat Rev Nephrol"},{"key":"1574_CR11","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3390\/toxins9040114","volume":"9","author":"E Castillo-Rodr\u00edguez","year":"2017","unstructured":"Castillo-Rodr\u00edguez E, Pizarro-S\u00e1nchez S, Sanz AB, Ramos AM, Sanchez-Ni\u00f1o MD, Martin-Cleary C, Fernandez-Fernandez B, Ortiz A. Inflammatory cytokines as uremic toxins: \u201cNi Son Todos Los Que Estan, Ni Estan Todos Los Que Son.\u201d Toxins. 2017;9:114.","journal-title":"Toxins"},{"key":"1574_CR12","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.2215\/cjn.13121215","volume":"11","author":"RL Amdur","year":"2016","unstructured":"Amdur RL, Feldman HI, Gupta J, Yang W, Kanetsky P, Shlipak M, Rahman M, Lash JP, Townsend RR, Ojo A, et al. Inflammation and progression of CKD: the CRIC study. Clin J Am Soc Nephrol. 2016;11:1546\u201356. https:\/\/doi.org\/10.2215\/cjn.13121215.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1574_CR13","doi-asserted-by":"publisher","first-page":"1814304","DOI":"10.1155\/2019\/1814304","volume":"2019","author":"S Mihai","year":"2019","unstructured":"Mihai S, Codrici E, Popescu ID, Enciu A-M, Rusu E, Zilisteanu D, Necula LG, Anton G, Tanase C. Inflammation-related patterns in the clinical staging and severity assessment of chronic kidney disease. Dis Markers. 2019;2019:1814304. https:\/\/doi.org\/10.1155\/2019\/1814304.","journal-title":"Dis Markers"},{"key":"1574_CR14","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1038\/sj.ki.5001969","volume":"70","author":"CM Avesani","year":"2006","unstructured":"Avesani CM, Carrero JJ, Axelsson J, Qureshi AR, Lindholm B, Stenvinkel P. Inflammation and wasting in chronic kidney disease: partners in crime. Kidney Int. 2006;70:S8\u201313. https:\/\/doi.org\/10.1038\/sj.ki.5001969.","journal-title":"Kidney Int"},{"key":"1574_CR15","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.cca.2020.03.040","volume":"506","author":"S Mazzaferro","year":"2020","unstructured":"Mazzaferro S, De Martini N, Rotondi S, Tartaglione L, Ure\u00f1a-Torres P, Bover J, Pasquali M. Bone, inflammation and chronic kidney disease. Clin Chim Acta. 2020;506:236\u201340. https:\/\/doi.org\/10.1016\/j.cca.2020.03.040.","journal-title":"Clin Chim Acta"},{"key":"1574_CR16","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1053\/j.ajkd.2008.10.044","volume":"53","author":"LD Bash","year":"2009","unstructured":"Bash LD, Erlinger TP, Coresh J, Marsh-Manzi J, Folsom AR, Astor BC. Inflammation, hemostasis, and the risk of kidney function decline in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis. 2009;53:596\u2013605. https:\/\/doi.org\/10.1053\/j.ajkd.2008.10.044.","journal-title":"Am J Kidney Dis"},{"key":"1574_CR17","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1053\/j.ajkd.2018.09.012","volume":"73","author":"RL Amdur","year":"2019","unstructured":"Amdur RL, Feldman HI, Dominic EA, Anderson AH, Beddhu S, Rahman M, Wolf M, Reilly M, Ojo A, Townsend RR, et al. Use of measures of inflammation and kidney function for prediction of atherosclerotic vascular disease events and death in patients with CKD: findings from the CRIC study. Am J Kidney Dis. 2019;73:344\u201353. https:\/\/doi.org\/10.1053\/j.ajkd.2018.09.012.","journal-title":"Am J Kidney Dis"},{"key":"1574_CR18","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1111\/j.1523-1755.2005.00455.x","volume":"68","author":"V Menon","year":"2005","unstructured":"Menon V, Greene T, Wang X, Pereira AA, Marcovina SM, Beck GJ, Kusek JW, Collins AJ, Levey AS, Sarnak MJ. C-reactive protein and albumin as predictors of all-cause and cardiovascular mortality in chronic kidney disease. Kidney Int. 2005;68:766\u201372. https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00455.x.","journal-title":"Kidney Int"},{"key":"1574_CR19","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.2215\/cjn.10441015","volume":"11","author":"J Sun","year":"2016","unstructured":"Sun J, Axelsson J, Machowska A, Heimb\u00fcrger O, B\u00e1r\u00e1ny P, Lindholm B, Lindstr\u00f6m K, Stenvinkel P, Qureshi AR. Biomarkers of cardiovascular disease and mortality risk in patients with advanced CKD. Clin J Am Soc Nephrol. 2016;11:1163\u201372. https:\/\/doi.org\/10.2215\/cjn.10441015.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1574_CR20","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.biochi.2014.06.024","volume":"105","author":"PM Alix","year":"2014","unstructured":"Alix PM, Guebre-Egziabher F, Soulage CO. Leptin as an uremic toxin: deleterious role of leptin in chronic kidney disease. Biochimie. 2014;105:12\u201321. https:\/\/doi.org\/10.1016\/j.biochi.2014.06.024.","journal-title":"Biochimie"},{"key":"1574_CR21","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/joim.12411","volume":"279","author":"B Sj\u00f6berg","year":"2016","unstructured":"Sj\u00f6berg B, Qureshi AR, Heimb\u00fcrger O, Stenvinkel P, Lind L, Larsson A, B\u00e1r\u00e1ny P, \u00c4rnl\u00f6v J. Association between levels of pentraxin 3 and incidence of chronic kidney disease in the elderly. J Intern Med. 2016;279:173\u20139. https:\/\/doi.org\/10.1111\/joim.12411.","journal-title":"J Intern Med"},{"key":"1574_CR22","doi-asserted-by":"publisher","first-page":"3295725","DOI":"10.1155\/2019\/3295725","volume":"2019","author":"MJ Valente","year":"2019","unstructured":"Valente MJ, Rocha S, Coimbra S, Catarino C, Rocha-Pereira P, Bronze-da-Rocha E, Oliveira JG, Madureira J, Fernandes JC, do Sameiro-Faria M, et al. Long pentraxin 3 as a broader biomarker for multiple risk factors in end-stage renal disease: association with all-cause mortality. Mediators Inflamm. 2019;2019:3295725\u20133295725. https:\/\/doi.org\/10.1155\/2019\/3295725.","journal-title":"Mediators Inflamm"},{"key":"1574_CR23","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1681\/asn.2011060628","volume":"23","author":"T Gohda","year":"2012","unstructured":"Gohda T, Niewczas MA, Ficociello LH, Walker WH, Skupien J, Rosetti F, Cullere X, Johnson AC, Crabtree G, Smiles AM, et al. Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes. J Am Soc Nephrol. 2012;23:516\u201324. https:\/\/doi.org\/10.1681\/asn.2011060628.","journal-title":"J Am Soc Nephrol"},{"key":"1574_CR24","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1681\/asn.2011060627","volume":"23","author":"MA Niewczas","year":"2012","unstructured":"Niewczas MA, Gohda T, Skupien J, Smiles AM, Walker WH, Rosetti F, Cullere X, Eckfeldt JH, Doria A, Mayadas TN, et al. Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. J Am Soc Nephrol. 2012;23:507\u201315. https:\/\/doi.org\/10.1681\/asn.2011060627.","journal-title":"J Am Soc Nephrol"},{"key":"1574_CR25","doi-asserted-by":"publisher","first-page":"226","DOI":"10.2337\/dc13-0985","volume":"37","author":"AS Krolewski","year":"2014","unstructured":"Krolewski AS, Niewczas MA, Skupien J, Gohda T, Smiles A, Eckfeldt JH, Doria A, Warram JH. Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria. Diabetes Care. 2014;37:226\u201334. https:\/\/doi.org\/10.2337\/dc13-0985.","journal-title":"Diabetes Care"},{"key":"1574_CR26","doi-asserted-by":"publisher","first-page":"F1141","DOI":"10.1152\/ajprenal.00344.2010","volume":"299","author":"CC Chen","year":"2010","unstructured":"Chen CC, Pedraza PL, Hao S, Stier CT, Ferreri NR. TNFR1-deficient mice display altered blood pressure and renal responses to ANG II infusion. Am J Physiol Renal Physiol. 2010;299:F1141-1150. https:\/\/doi.org\/10.1152\/ajprenal.00344.2010.","journal-title":"Am J Physiol Renal Physiol"},{"key":"1574_CR27","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1172\/jci23348","volume":"115","author":"V Vielhauer","year":"2005","unstructured":"Vielhauer V, Stavrakis G, Mayadas TN. Renal cell-expressed TNF receptor 2, not receptor 1, is essential for the development of glomerulonephritis. J Clin Invest. 2005;115:1199\u2013209. https:\/\/doi.org\/10.1172\/jci23348.","journal-title":"J Clin Invest"},{"key":"1574_CR28","doi-asserted-by":"publisher","first-page":"F766","DOI":"10.1152\/ajprenal.1999.277.5.F766","volume":"277","author":"G Guo","year":"1999","unstructured":"Guo G, Morrissey J, McCracken R, Tolley T, Klahr S. Role of TNFR1 and TNFR2 receptors in tubulointerstitial fibrosis of obstructive nephropathy. Am J Physiol. 1999;277:F766-772. https:\/\/doi.org\/10.1152\/ajprenal.1999.277.5.F766.","journal-title":"Am J Physiol"},{"key":"1574_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1600-6143.2009.02834.x","volume":"3","author":"A Levin","year":"2012","unstructured":"Levin A, Stevens PE, Bilous RW, Coresh J, De Francisco ALM, De Jong PE, Griffith KE, Hemmelgarn BR, Iseki K, Lamb EJ, Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group, et al. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2012;3:1\u2013150. https:\/\/doi.org\/10.1111\/j.1600-6143.2009.02834.x.","journal-title":"Kidney Int Suppl"},{"key":"1574_CR30","doi-asserted-by":"publisher","first-page":"41","DOI":"10.17705\/1CAIS.02804","volume":"28","author":"G Templeton","year":"2011","unstructured":"Templeton G. A two-step approach for transforming continuous variables to normal: implications and recommendations for IS research. Commun Assoc Inf Syst. 2011;28:41\u201358. https:\/\/doi.org\/10.17705\/1CAIS.02804.","journal-title":"Commun Assoc Inf Syst"},{"key":"1574_CR31","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1046\/j.1365-2796.2000.00678.x","volume":"247","author":"L Hellstr\u00f6m","year":"2000","unstructured":"Hellstr\u00f6m L, Wahrenberg H, Hruska K, Reynisdottir S, Arner P. Mechanisms behind gender differences in circulating leptin levels. J Intern Med. 2000;247:457\u201362. https:\/\/doi.org\/10.1046\/j.1365-2796.2000.00678.x.","journal-title":"J Intern Med"},{"key":"1574_CR32","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejphar.2017.12.016","volume":"820","author":"W Lv","year":"2018","unstructured":"Lv W, Booz GW, Wang Y, Fan F, Roman RJ. Inflammation and renal fibrosis: recent developments on key signaling molecules as potential therapeutic targets. Eur J Pharmacol. 2018;820:65\u201376. https:\/\/doi.org\/10.1016\/j.ejphar.2017.12.016.","journal-title":"Eur J Pharmacol"},{"key":"1574_CR33","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1093\/ndt\/gfq471","volume":"26","author":"A Upadhyay","year":"2011","unstructured":"Upadhyay A, Larson MG, Guo CY, Vasan RS, Lipinska I, O\u2019Donnell CJ, Kathiresan S, Meigs JB, Keaney JF Jr, Rong J, et al. Inflammation, kidney function and albuminuria in the Framingham Offspring cohort. Nephrol Dial Transplant. 2011;26:920\u20136. https:\/\/doi.org\/10.1093\/ndt\/gfq471.","journal-title":"Nephrol Dial Transplant"},{"key":"1574_CR34","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/s0272-6386(99)70375-6","volume":"34","author":"M Heinzelmann","year":"1999","unstructured":"Heinzelmann M, Mercer-Jones MA, Passmore JC. Neutrophils and renal failure. Am J Kidney Dis. 1999;34:384\u201399. https:\/\/doi.org\/10.1016\/s0272-6386(99)70375-6.","journal-title":"Am J Kidney Dis"},{"key":"1574_CR35","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s12916-020-01817-1","volume":"18","author":"MA Cupp","year":"2020","unstructured":"Cupp MA, Cariolou M, Tzoulaki I, Aune D, Evangelou E, Berlanga-Taylor AJ. Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies. BMC Med. 2020;18:360. https:\/\/doi.org\/10.1186\/s12916-020-01817-1.","journal-title":"BMC Med"},{"key":"1574_CR36","doi-asserted-by":"publisher","first-page":"2703518","DOI":"10.1155\/2018\/2703518","volume":"2018","author":"T Angkananard","year":"2018","unstructured":"Angkananard T, Anothaisintawee T, McEvoy M, Attia J, Thakkinstian A. Neutrophil lymphocyte ratio and cardiovascular disease risk: a systematic review and meta-analysis. Biomed Res Int. 2018;2018:2703518\u20132703518. https:\/\/doi.org\/10.1155\/2018\/2703518.","journal-title":"Biomed Res Int"},{"key":"1574_CR37","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3109\/0886022X.2012.734429","volume":"35","author":"GU Okyay","year":"2013","unstructured":"Okyay GU, \u0130nal S, \u00d6ne\u00e7 K, Er RE, Pa\u015fao\u011flu \u00d6, Pa\u015fao\u011flu H, Derici \u00dc, Erten Y. Neutrophil to lymphocyte ratio in evaluation of inflammation in patients with chronic kidney disease. Ren Fail. 2013;35:29\u201336. https:\/\/doi.org\/10.3109\/0886022X.2012.734429.","journal-title":"Ren Fail"},{"key":"1574_CR38","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1080\/0886022X.2019.1595645","volume":"41","author":"R Yoshitomi","year":"2019","unstructured":"Yoshitomi R, Nakayama M, Sakoh T, Fukui A, Katafuchi E, Seki M, Tsuda S, Nakano T, Tsuruya K, Kitazono T. High neutrophil\/lymphocyte ratio is associated with poor renal outcomes in Japanese patients with chronic kidney disease. Ren Fail. 2019;41:238\u201343. https:\/\/doi.org\/10.1080\/0886022X.2019.1595645.","journal-title":"Ren Fail"},{"key":"1574_CR39","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s12967-019-1808-4","volume":"17","author":"Q Yuan","year":"2019","unstructured":"Yuan Q, Wang J, Peng Z, Zhou Q, Xiao X, Xie Y, Wang W, Huang L, Tang W, Sun D, et al. Neutrophil-to-lymphocyte ratio and incident end-stage renal disease in Chinese patients with chronic kidney disease: results from the Chinese Cohort Study of Chronic Kidney Disease (C-STRIDE). J Transl Med. 2019;17:86\u201386. https:\/\/doi.org\/10.1186\/s12967-019-1808-4.","journal-title":"J Transl Med"},{"key":"1574_CR40","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1080\/0886022X.2020.1832521","volume":"42","author":"W-M Zhao","year":"2020","unstructured":"Zhao W-M, Tao S-M, Liu G-L. Neutrophil-to-lymphocyte ratio in relation to the risk of all-cause mortality and cardiovascular events in patients with chronic kidney disease: a systematic review and meta-analysis. Ren Fail. 2020;42:1059\u201366. https:\/\/doi.org\/10.1080\/0886022X.2020.1832521.","journal-title":"Ren Fail"},{"key":"1574_CR41","first-page":"811","volume":"20","author":"G Abraham","year":"2009","unstructured":"Abraham G, Sundaram V, Sundaram V, Mathew M, Leslie N, Sathiah V. C-Reactive protein, a valuable predictive marker in chronic kidney disease. Saudi J Kidney Dis Transpl. 2009;20:811\u20135.","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"1574_CR42","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/978-3-319-16018-4_5","volume-title":"Biomarkers of cardiometabolic risk, inflammation and disease","author":"A Santos-Silva","year":"2015","unstructured":"Santos-Silva A, Costa E, Alves R. Chronic kidney disease. In: Palavra F, Reis F, Marado D, Sena A, editors. Biomarkers of cardiometabolic risk, inflammation and disease. Cham: Springer International Publishing; 2015. p. 95\u2013111. https:\/\/doi.org\/10.1007\/978-3-319-16018-4_5."},{"key":"1574_CR43","first-page":"893","volume":"31","author":"S Noor","year":"2018","unstructured":"Noor S, Alam F, Fatima SS, Khan M, Rehman R. Role of Leptin and dyslipidemia in chronic kidney disease. Pak J Pharm Sci. 2018;31:893\u20137.","journal-title":"Pak J Pharm Sci"},{"key":"1574_CR44","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2369-9-9","volume":"9","author":"C Keller","year":"2008","unstructured":"Keller C, Katz R, Cushman M, Fried LF, Shlipak M. Association of kidney function with inflammatory and procoagulant markers in a diverse cohort: a cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis (MESA). BMC Nephrol. 2008;9:9. https:\/\/doi.org\/10.1186\/1471-2369-9-9.","journal-title":"BMC Nephrol"},{"key":"1574_CR45","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1523-1755.2005.00398.x","volume":"68","author":"M Tonelli","year":"2005","unstructured":"Tonelli M, Sacks F, Pfeffer M, Jhangri GS, Curhan G. Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int. 2005;68:237\u201345. https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00398.x.","journal-title":"Kidney Int"},{"key":"1574_CR46","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1038\/ki.2011.283","volume":"80","author":"A Shankar","year":"2011","unstructured":"Shankar A, Sun L, Klein BEK, Lee KE, Muntner P, Nieto FJ, Tsai MY, Cruickshanks KJ, Schubert CR, Brazy PC, et al. Markers of inflammation predict the long-term risk of developing chronic kidney disease: a population-based cohort study. Kidney Int. 2011;80:1231\u20138. https:\/\/doi.org\/10.1038\/ki.2011.283.","journal-title":"Kidney Int"},{"key":"1574_CR47","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/ki.2014.285","volume":"87","author":"RS Al-Lamki","year":"2015","unstructured":"Al-Lamki RS, Mayadas TN. TNF receptors: signaling pathways and contribution to renal dysfunction. Kidney Int. 2015;87:281\u201396. https:\/\/doi.org\/10.1038\/ki.2014.285.","journal-title":"Kidney Int"},{"key":"1574_CR48","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1038\/labinvest.3780364","volume":"81","author":"RS Al-Lamki","year":"2001","unstructured":"Al-Lamki RS, Wang J, Skepper JN, Thiru S, Pober JS, Bradley JR. Expression of tumor necrosis factor receptors in normal kidney and rejecting renal transplants. Lab Invest. 2001;81:1503\u201315. https:\/\/doi.org\/10.1038\/labinvest.3780364.","journal-title":"Lab Invest"},{"key":"1574_CR49","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s11892-013-0385-9","volume":"13","author":"T Gohda","year":"2013","unstructured":"Gohda T, Tomino Y. Novel biomarkers for the progression of diabetic nephropathy: soluble TNF receptors. Curr Diab Rep. 2013;13:560\u20136. https:\/\/doi.org\/10.1007\/s11892-013-0385-9.","journal-title":"Curr Diab Rep"},{"key":"1574_CR50","doi-asserted-by":"publisher","first-page":"15302","DOI":"10.1038\/s41598-018-33590-w","volume":"8","author":"N Kamei","year":"2018","unstructured":"Kamei N, Yamashita M, Nishizaki Y, Yanagisawa N, Nojiri S, Tanaka K, Yamashita Y, Shibata T, Murakoshi M, Suzuki Y, et al. Association between circulating tumor necrosis factor-related biomarkers and estimated glomerular filtration rate in type 2 diabetes. Sci Rep. 2018;8:15302. https:\/\/doi.org\/10.1038\/s41598-018-33590-w.","journal-title":"Sci Rep"},{"key":"1574_CR51","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.1681\/asn.2016101101","volume":"28","author":"SG Coca","year":"2017","unstructured":"Coca SG, Nadkarni GN, Huang Y, Moledina DG, Rao V, Zhang J, Ferket B, Crowley ST, Fried LF, Parikh CR. Plasma biomarkers and kidney function decline in early and established diabetic kidney disease. J Am Soc Nephrol. 2017;28:2786\u201393. https:\/\/doi.org\/10.1681\/asn.2016101101.","journal-title":"J Am Soc Nephrol"},{"key":"1574_CR52","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3389\/fimmu.2018.00784","volume":"9","author":"S Yang","year":"2018","unstructured":"Yang S, Wang J, Brand DD, Zheng SG. Role of TNF-TNF receptor 2 signal in regulatory T cells and its therapeutic implications. Front Immunol. 2018;9:784. https:\/\/doi.org\/10.3389\/fimmu.2018.00784.","journal-title":"Front Immunol"},{"key":"1574_CR53","doi-asserted-by":"publisher","first-page":"585880","DOI":"10.3389\/fimmu.2020.585880","volume":"11","author":"P Gough","year":"2020","unstructured":"Gough P, Myles IA. Tumor necrosis factor receptors: pleiotropic signaling complexes and their differential effects. Front Immunol. 2020;11:585880\u2013585880. https:\/\/doi.org\/10.3389\/fimmu.2020.585880.","journal-title":"Front Immunol"},{"key":"1574_CR54","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/labinvest.2010.199","volume":"91","author":"LA Bruggeman","year":"2011","unstructured":"Bruggeman LA, Drawz PE, Kahoud N, Lin K, Barisoni L, Nelson PJ. TNFR2 interposes the proliferative and NF-\u03baB-mediated inflammatory response by podocytes to TNF-\u03b1. Lab Invest. 2011;91:413\u201325. https:\/\/doi.org\/10.1038\/labinvest.2010.199.","journal-title":"Lab Invest"},{"key":"1574_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25225474","author":"S Saha","year":"2020","unstructured":"Saha S, Buttari B, Panieri E, Profumo E, Saso L. An overview of Nrf2 signaling pathway and its role in inflammation. Molecules. 2020. https:\/\/doi.org\/10.3390\/molecules25225474.","journal-title":"Molecules"},{"key":"1574_CR56","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfab031","author":"C Juul-Nielsen","year":"2021","unstructured":"Juul-Nielsen C, Shen J, Stenvinkel P, Scholze A. Systematic review of the nuclear factor erythroid 2-related factor 2 (NRF2) system in human chronic kidney disease: alterations, interventions, and relation to morbidity. Nephrol Dial Transplant. 2021. https:\/\/doi.org\/10.1093\/ndt\/gfab031.","journal-title":"Nephrol Dial Transplant"},{"key":"1574_CR57","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/j.ekir.2021.04.023","volume":"6","author":"P Stenvinkel","year":"2021","unstructured":"Stenvinkel P, Chertow GM, Devarajan P, Levin A, Andreoli SP, Bangalore S, Warady BA. Chronic inflammation in chronic kidney disease progression: role of Nrf2. Kidney Int Rep. 2021;6:1775\u201387. https:\/\/doi.org\/10.1016\/j.ekir.2021.04.023.","journal-title":"Kidney Int Rep"},{"key":"1574_CR58","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1681\/asn.2013080906","volume":"25","author":"S Martini","year":"2014","unstructured":"Martini S, Nair V, Keller BJ, Eichinger F, Hawkins JJ, Randolph A, B\u00f6ger CA, Gadegbeku CA, Fox CS, Cohen CD, et al. Integrative biology identifies shared transcriptional networks in CKD. J Am Soc Nephrol. 2014;25:2559\u201372. https:\/\/doi.org\/10.1681\/asn.2013080906.","journal-title":"J Am Soc Nephrol"},{"key":"1574_CR59","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1600-6143.2008.02536.x","volume":"9","author":"U Hoffmann","year":"2009","unstructured":"Hoffmann U, Bergler T, Rihm M, Pace C, Kr\u00fcger B, R\u00fcmmele P, Stoelcker B, Banas B, M\u00e4nnel DN, Kr\u00e4mer BK. Upregulation of TNF receptor type 2 in human and experimental renal allograft rejection. Am J Transplant. 2009;9:675\u201386. https:\/\/doi.org\/10.1111\/j.1600-6143.2008.02536.x.","journal-title":"Am J Transplant"},{"key":"1574_CR60","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1046\/j.1523-1755.2003.00762.x","volume":"63","author":"EM Stuveling","year":"2003","unstructured":"Stuveling EM, Hillege HL, Bakker SJ, Gans RO, De Jong PE, De Zeeuw D. C-reactive protein is associated with renal function abnormalities in a non-diabetic population. Kidney Int. 2003;63:654\u201361. https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00762.x.","journal-title":"Kidney Int"},{"key":"1574_CR61","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3389\/fimmu.2017.00405","volume":"8","author":"H Su","year":"2017","unstructured":"Su H, Lei CT, Zhang C. Interleukin-6 signaling pathway and its role in kidney disease: an update. Front Immunol. 2017;8:405. https:\/\/doi.org\/10.3389\/fimmu.2017.00405.","journal-title":"Front Immunol"},{"key":"1574_CR62","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.34172\/jnp.2020.39","volume":"9","author":"A Soleimani","year":"2020","unstructured":"Soleimani A, Soleimani M, Farzadnejad F, Tamadon M. The relationship between urinary and plasma levels of tumor necrosis factor alpha and various stages of chronic kidney disease in patients with type II diabetes mellitus. J Nephropathol. 2020;9:e39\u2013e39. https:\/\/doi.org\/10.34172\/jnp.2020.39.","journal-title":"J Nephropathol"},{"key":"1574_CR63","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/s0272-6386(03)00408-6","volume":"42","author":"JF Navarro","year":"2003","unstructured":"Navarro JF, Mora C, Maca M, Garca J. Inflammatory parameters are independently associated with urinary albumin in type 2 diabetes mellitus. Am J Kidney Dis. 2003;42:53\u201361. https:\/\/doi.org\/10.1016\/s0272-6386(03)00408-6.","journal-title":"Am J Kidney Dis"},{"key":"1574_CR64","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3346\/jkms.2013.28.2.261","volume":"28","author":"R Zwiech","year":"2013","unstructured":"Zwiech R. Predictive value of conjointly examined IL-1ra, TNF-R I, TNF-R II, and RANTES in patients with primary glomerulonephritis. J Korean Med Sci. 2013;28:261\u20137. https:\/\/doi.org\/10.3346\/jkms.2013.28.2.261.","journal-title":"J Korean Med Sci"},{"key":"1574_CR65","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1053\/ajkd.2003.50024","volume":"41","author":"J Iglesias","year":"2003","unstructured":"Iglesias J, Marik PE, Levine JS. Elevated serum levels of the type I and type II receptors for tumor necrosis factor-alpha as predictive factors for ARF in patients with septic shock. Am J Kidney Dis. 2003;41:62\u201375. https:\/\/doi.org\/10.1053\/ajkd.2003.50024.","journal-title":"Am J Kidney Dis"}],"container-title":["Inflammation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-022-01574-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00011-022-01574-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00011-022-01574-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T09:09:51Z","timestamp":1654247391000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00011-022-01574-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,26]]},"references-count":65,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["1574"],"URL":"https:\/\/doi.org\/10.1007\/s00011-022-01574-2","relation":{},"ISSN":["1023-3830","1420-908X"],"issn-type":[{"type":"print","value":"1023-3830"},{"type":"electronic","value":"1420-908X"}],"subject":[],"published":{"date-parts":[[2022,4,26]]},"assertion":[{"value":"20 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}